| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02893498 |
| P698 | PubMed publication ID | 17922047 |
| P50 | author | Zsuzsa Schaff | Q1285946 |
| Zsuzsanna Németh | Q81408246 | ||
| Andras Kiss | Q104742702 | ||
| P2093 | author name string | Gábor Lotz | |
| Imre Romics | |||
| Ilona Kovalszky | |||
| Csilla Páska | |||
| Péter Törzsök | |||
| Tibor Szarvas | |||
| Péter Riesz | |||
| Attila Majoros | |||
| Attila Szendrôi | |||
| P2860 | cites work | Guidelines on bladder cancer | Q34695710 |
| Tumor markers in the diagnosis of primary bladder cancer. A systematic review | Q35138568 | ||
| Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology | Q38452177 | ||
| New methods for detection of bladder cancer | Q41723584 | ||
| Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations | Q43784757 | ||
| Estimates of the worldwide incidence of 25 major cancers in 1990. | Q50638996 | ||
| A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. | Q53671273 | ||
| Molecular detection of primary bladder cancer by microsatellite analysis | Q70923967 | ||
| Superficial bladder cancer: progression and recurrence | Q71108025 | ||
| Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer | Q71226054 | ||
| A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma | Q73062815 | ||
| Detection of bladder cancer recurrence by microsatellite analysis of urine | Q73400015 | ||
| Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder | Q73589234 | ||
| Bladder cancer: state-of-the-art care | Q77317814 | ||
| Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer? | Q81746028 | ||
| P4510 | describes a project that uses | fluorescence in situ hybridization | Q1336182 |
| P433 | issue | 3 | |
| P921 | main subject | bladder cancer | Q504775 |
| P304 | page(s) | 187-194 | |
| P577 | publication date | 2007-10-07 | |
| P1433 | published in | Pathology and Oncology Research | Q26842743 |
| P1476 | title | Detection of bladder cancer from the urine using fluorescence in situ hybridization technique | |
| P478 | volume | 13 |
| Q37781786 | A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis |
| Q36770389 | Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests |
| Q33915293 | Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand? |
| Q51297927 | Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma |
| Q48914536 | Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization. |
| Q37507532 | Diagnosis of urothelial carcinoma from urine |
| Q34361348 | Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study |
| Q34634621 | Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection |
| Q82747417 | Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma |
| Q84795934 | Individual risk assessment in bladder cancer patients based on a multi-marker panel |
| Q53156367 | Influence of age on false positive rates of urine-based tumor markers. |
| Q83563654 | Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer |
| Q88417573 | No influence of smoking status on the performance of urine markers for the detection of bladder cancer |
| Q35219041 | Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. |
| Q34838223 | Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer |
| Q37197686 | The current role of telomerase in the diagnosis of bladder cancer |
| Q38138607 | Urinary biomarkers of bladder cancer: an update and future perspectives |
| Q39763864 | Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria |
| Q83781656 | [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?] |
Search more.